LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Saidel, Matthew L"
  2. AU="Elliott, Okla"

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Non-Invasive prenatal testing with rolling circle amplification: Real-world clinical experience in a non-molecular laboratory.

    Saidel, Matthew L / Ananth, Uma / Rose, Donna / Farrell, Cara

    Journal of clinical laboratory analysis

    2023  Volume 37, Issue 6, Page(s) e24870

    Abstract: Background: Non-invasive prenatal testing (NIPT) using cell-free DNA (cfDNA) circulating in maternal blood provides a sensitive and specific screening technique for common fetal aneuploidies, but the high cost and workflow complexity of conventional ... ...

    Abstract Background: Non-invasive prenatal testing (NIPT) using cell-free DNA (cfDNA) circulating in maternal blood provides a sensitive and specific screening technique for common fetal aneuploidies, but the high cost and workflow complexity of conventional methodologies limit its widespread implementation. A unique rolling circle amplification methodology reduces cost and complexity, providing a promising alternative for increased global accessibility as a first-tier test.
    Methods: In this clinical study, 8160 pregnant women were screened on the Vanadis system for trisomies 13, 18, and 21, and positive results were compared to clinical outcomes where available.
    Results: The Vanadis system yielded a 0.07% no-call rate, a 98% overall sensitivity, and a specificity of over 99% based on available outcomes.
    Conclusion: The Vanadis system provided a sensitive, specific, and cost-effective cfDNA assay for trisomies 13, 18, and 21, with good performance characteristics and low no-call rate, and it eliminated the need for either next-generation sequencing or polymerase chain reaction amplification.
    MeSH term(s) Pregnancy ; Humans ; Female ; Prenatal Diagnosis/methods ; Trisomy/diagnosis ; Trisomy/genetics ; Aneuploidy ; Trisomy 13 Syndrome/diagnosis ; Trisomy 13 Syndrome/genetics ; Cell-Free Nucleic Acids/genetics ; Cell-Free Nucleic Acids/analysis
    Chemical Substances Cell-Free Nucleic Acids
    Language English
    Publishing date 2023-03-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 645095-7
    ISSN 1098-2825 ; 0887-8013
    ISSN (online) 1098-2825
    ISSN 0887-8013
    DOI 10.1002/jcla.24870
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cell-free DNA-based prenatal screening via rolling circle amplification: Identifying and resolving analytic issues.

    Palomaki, Glenn E / Lambert-Messerlian, Geralyn M / Fullerton, Donna / Hegde, Madhuri / Conotte, Stéphanie / Saidel, Matthew L / Jani, Jacques C

    Journal of medical screening

    2023  Volume 30, Issue 4, Page(s) 168–174

    Abstract: Objective: A rolling circle amplification (RCA) based commercial methodology using cell-free (cf)DNA to screen for common trisomies became available in 2018. Relevant publications documented high detection but with a higher than expected 1% false ... ...

    Abstract Objective: A rolling circle amplification (RCA) based commercial methodology using cell-free (cf)DNA to screen for common trisomies became available in 2018. Relevant publications documented high detection but with a higher than expected 1% false positive rate. Preliminary evidence suggested assay variability was an issue. A multi-center collaboration was created to explore this further and examine whether subsequent manufacturer changes were effective.
    Methods: Three academic (four devices) and two commercial (two devices) laboratories provided run date, chromosome 21, 18, and 13 run-specific standard deviations, number of samples run, and reagent lot identifications. Temporal trends and between-site/device consistency were explored. Proportions of run standard deviations exceeding pre-specified caps of 0.4%, 0.4% and 0.6% were computed.
    Results: Overall, 661 RCA runs between April 2019 and July 30, 2022 tested 39,756 samples. In the first 24, subsequent 9, and final 7 months, proportions of capped chromosome 21 runs dropped from 39% to 22% to 6.0%; for chromosome 18, rates were 76%, 36%, and 4.0%. Few chromosome 13 runs were capped using the original 0.60%, but capping at 0.50%, rates were 28%, 16%, and 7.6%. Final rates occurred after reformulated reagents and imaging software modifications were fully implemented across all devices. Revised detection and false positive rates are estimated at 98.4% and 0.3%, respectively. After repeat testing, failure rates may be as low as 0.3%.
    Conclusion: Current RCA-based screening performance estimates are equivalent to those reported for other methods, but with a lower test failure rate after repeat testing.
    MeSH term(s) Pregnancy ; Female ; Humans ; Cell-Free Nucleic Acids/genetics ; Early Detection of Cancer ; Prenatal Diagnosis/methods ; Trisomy/diagnosis ; Trisomy/genetics
    Chemical Substances Cell-Free Nucleic Acids
    Language English
    Publishing date 2023-05-17
    Publishing country England
    Document type Journal Article
    ZDB-ID 1235253-6
    ISSN 1475-5793 ; 0969-1413
    ISSN (online) 1475-5793
    ISSN 0969-1413
    DOI 10.1177/09691413231173315
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top